Ironwood Pharma Inc Class A (IRWD)

R&D Expense Growth

4.30%

Quarterly · Period ending:

IRWD logo

IRWD R&D Expense Growth

Latest reported4.30%
IRWD Quarterly R&D Growth (QoQ) (0.00% → 4.30%)
High-resolution chart · PNG

IRWD r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Ironwood Pharma Inc Class A R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
4.2983%
-1.6741%
-0.5911%
-3.9859%
-16.499%
8.0383%
-14.8724%
-1.8461%
17.7145%
-27.6404%
10.5273%
-97.1309%
8,856.5003%
24.2925%
-9.6226%
0.8114%
2.4949%
-65.6368%
188.7412%
-10.3264%
-33.8392%
13.0141%
-25.0092%
1.1943%
-23.5166%
5.6148%
-3.6804%
-4.1971%
-46.7346%
21.9507%
-5.3896%
20.1942%
6.6484%
-9.0037%
8.2342%
-0.7471%
10.8065%
-12.3303%
2.441%
18.4458%
-0.5025%
15.2568%
6.957%
-9.8366%
7.5335%
-3.0602%
9.3942%
13.4586%
-18.4276%
20.5543%
-2.1724%
-4.4702%
-26.4403%
15.8455%
20.5517%
-27.2504%
9.2443%
21.8213%
5.7586%
18.0123%
-0.7466%
-8.0457%
13.4671%
-10.5522%
12.4269%
-28.5062%
40.1279%
-4.0934%
4.2457%
12.7697%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.